Subscribe To
Biocardia shares slide on disappointing interim data from heart therapy trial
BioCardia shares fell more than 20% in pre-market trade on Tuesday after the biopharmaceutical firm revealed that its ...
September 5, 2023, 9:31 am
Moleculin to present at the h.c. wainwright 25th annual global investment conference
HOUSTON , Sept. 5, 2023 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical compan...
September 5, 2023, 8:35 am
Gold price forecast: xau/usd struggles below $1,950 amid a bear cross
Gold price is trading on the back foot below $1,950 early Tuesday, although remains within Friday’s trading range. The United States Dollar (USD) ha...
September 5, 2023, 4:14 am
Enphase: growing pains persist, spotting one key price level, shares undervalued
The Invesco Solar ETF (TAN) is down 20% in 2023, while the S&P 500 is up, highlighting a tough year for solar stocks. En...
September 5, 2023, 3:22 am
Enphase energy: is it cheap enough?
Enphase Energy's stock has fallen 51% this year and is now the worst performer in the S&P 500. The comp...
September 5, 2023, 2:53 am
Zevra's rare find: unearthing value in niche rare diseases the market overlooks
Zevra's acquisition of Acer Therapeutics adds significant value to its rare disease-focused strategy. Acer's newly launched product, Olpruva, aligns w...
September 5, 2023, 1:30 am
Genmab, seagen say tivdak cervical cancer trial met overall survival endpoint
Genmab A/S , and Seagen Inc on Monday said that the phase III trial of Tivdak in recurrent or metastati...
September 4, 2023, 5:33 pm
Squaredfinancial group calls on global talents to shape the future of online trading
Founder and CEO of SquaredFinancial Group Philippe Ghanem, a 20-year veteran in the financial industry, has issued an inspiring call for talents to jo...
September 4, 2023, 10:25 am
Protagonist therapeutics: evaluating rusfertide's potential for pv
Protagonist Therapeutics focuses on peptide-based drugs, primarily rusfertide, which is undergoing a phase ...
September 4, 2023, 2:56 am
Wti oil technical: risk of countertrend setback after rallying a year-to-date high
Erased prior two weeks of consecutive losing streaks to trade a current year-to-date closing high of US$86.31 per barrel printed on last Friday, 1 Sep...
September 4, 2023, 2:39 am
Wti oil technical: risk of countertrend setback after rallying a year-to-date high
Erased prior two weeks of consecutive losing streaks to trade a current year-to-date closing high of US$86.31 per barrel printed on last Friday, 1 Sep...
September 4, 2023, 2:27 am
Turnstone biologics corp. reports second quarter 2023 financial results and provides business update
Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programs Cash position e...
September 1, 2023, 9:57 pm
Relmada therapeutics: run up likely into phase 3 results, enhanced by possible interim readout
Relmada Therapeutics has provided updates on its phase 3 program of esmethadone (REL-1017) as an adjunc...
September 1, 2023, 6:53 pm
Seres therapeutics: approved drug and nestle partnership make it a buy
Seres Therapeutics trades near its 52-week low and presents an asymmetric risk-reward profile. The company's lead asset, SER-109, has successfully con...
September 1, 2023, 2:03 pm
Usdjpy daily analysis – september 1, 2023
USD/JPY is currently within a rising price channel on the 4-hour chart, indicating that the pair remains in an uptrend from 138.05. As long as the sup...
September 1, 2023, 9:38 am
Eurusd daily analysis – september 1, 2023
EUR/USD has recently broken above a falling price channel on the 4-hour chart, indicating a shift to an uptrend from the 1.0765 level. The pullback fr...
September 1, 2023, 9:09 am
How big are innovative industrial's customer problems today?
Innovative Industrial Properties owns marijuana growing facilities. The pot sector is going through a shakeout after a rapid growth phase....
September 1, 2023, 8:08 am
Libertine holdings completes phases of work with mahle and hyliion
Libertine Holdings PLC (AIM:LIB) said it has completed work on the UK government-funded development with MAHLE Powertrain and on the first ...
September 1, 2023, 4:23 am
The second phase of the uranium bull market has likely started
The second phase of the uranium bull market has started and Global X Uranium ETF (URA) will benefit. A ...
September 1, 2023, 3:46 am
Why novocure stock fell 24.4% this week
On Monday, Novocure announced a key phase 3 trial evaluating its Tumor Treating Fields (TTFields) thera...
August 31, 2023, 6:52 pm